Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Tolerability,”

19,001 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 19,001 results

Large-scale testing (Phase 3)Looking for participantsNCT07293260
What this trial is testing

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial

Who this might be right for
Cardiovascular Disease
Amgen 406
Early research (Phase 1)Study completedNCT04208620
What this trial is testing

Safety and Tolerability Study of Cotadutide in Japanese Obese Subjects With Type 2 Diabetes Melitus

Who this might be right for
Type 2 Diabetes
AstraZeneca 16
Testing effectiveness (Phase 2)Study completedNCT03078582
What this trial is testing

Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Ra Pharmaceuticals 26
Large-scale testing (Phase 3)Study completedNCT00171379
What this trial is testing

Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium After Equimolar Conversion From Mycophenolate Mofetil (MMF) in Patients With Renal Transplant

Who this might be right for
Prevention of Acute Rejection After Kidney Transplantation
Novartis 162
Testing effectiveness (Phase 2)Looking for participantsNCT06520488
What this trial is testing

HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd. 118
Early research (Phase 1)Study completedNCT00027261
What this trial is testing

Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 110
Early research (Phase 1)Looking for participantsNCT07080242
What this trial is testing

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

Who this might be right for
Small Cell Lung Cancer Metastatic or Locally AdvancedNeuroendocrine CancerMetastatic or Locally Advanced Neuroendocrine Prostate Cancer+5 more
SystImmune Inc. 120
Testing effectiveness (Phase 2)Ended earlyNCT03354754
What this trial is testing

LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI)

Who this might be right for
Intra-abdominal Infections
Novartis Pharmaceuticals 3
Early research (Phase 1)Study completedNCT02151994
What this trial is testing

Safety, Tolerability, Pharmacokinetic, Including Food Interaction, and Pharmacodynamic Profile of BIA 5-1058.

Who this might be right for
Hypertension and Chronic Heart Failure
Bial - Portela C S.A. 124
Testing effectiveness (Phase 2)Ended earlyNCT05301894
What this trial is testing

Extension Study to Evaluate NBI-827104 in Pediatric Participants With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep

Who this might be right for
Epileptic EncephalopathyContinuous Spike and Wave During Sleep
Neurocrine Biosciences 19
Early research (Phase 1)Ended earlyNCT04199351
What this trial is testing

Single and Multiple Ascending Dose Study of AMG 171 in Subjects With Obesity

Who this might be right for
Obesity
Amgen 60
Early research (Phase 1)Ended earlyNCT03757351
What this trial is testing

Study to Evaluate DNL747 in Subjects With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Sanofi 15
Early research (Phase 1)Ended earlyNCT05156229
What this trial is testing

A Phase 1/2a Study of CDK-003 in Patients With Cutaneous T-Cell Lymphoma (CTCL).

Who this might be right for
Cutaneous T-cell Lymphoma (CTCL)
Codiak BioSciences 2
Early research (Phase 1)Study completedNCT03054402
What this trial is testing

First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of BAY1834845

Who this might be right for
Pelvic Inflammatory Disease
Bayer 70
Early research (Phase 1)Study completedNCT07300202
What this trial is testing

CLINICAL RESEARCH PROTOCOL [A Phase I, Single-arm, Open-label, Dose-escalation Clinical Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers]

Who this might be right for
Evaluate the Safety Profile and Tolerability of Orialpha in Healthy Adult VolunteersBreast Cancer
Oriplantee Company Limited 15
Testing effectiveness (Phase 2)Study completedNCT00283959
What this trial is testing

A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease

Who this might be right for
Fabry Disease
Amicus Therapeutics 4
Early research (Phase 1)Looking for participantsNCT06859762
What this trial is testing

A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
MediLink Therapeutics (Suzhou) Co., Ltd. 220
Early research (Phase 1)Study completedNCT02454062
What this trial is testing

A Trial of TAS-114 in Combination With S-1

Who this might be right for
Advanced Solid Tumors
Taiho Oncology, Inc. 120
Early research (Phase 1)Not Yet RecruitingNCT07479862
What this trial is testing

SA030 Injection in Overweight or Obese Participants

Who this might be right for
ObeseOverweight
Suzhou Siran Biotechnology Co.,Ltd. 40
Testing effectiveness (Phase 2)Ended earlyNCT02034227
What this trial is testing

Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaChronic Lymphocytic Leukemia
Spirogen 6
Load More Results